A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008191/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the efficacy and safety of MEDI-546 compared to
placebo in subjects with chronic, moderately-to-severely active systemic lupus erythematosus
(SLE) with an inadequate response to standard of care treatment for SLE.
提供机构：
Vivli
创建时间：
2022-07-06
